Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 3, 2006, Pages 1297-1306

  Woo, Sukyung ^a   Krzyzanski, Wojciech ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; ERYTHROCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETICULOCYTE;

ALGORITHMS; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD CELL COUNT; BONE MARROW CELLS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MODELS, STATISTICAL; RATS; RATS, WISTAR; RETICULOCYTE COUNT;

EID: 33751192917     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.111377     Document Type: Article

References (29)

1. Al-Huniti NH, Widness JA, Schmidt RL, and Veng-Pedersen P (2004) Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia. J Pharmacol Exp Ther 310:202-208.
2. Archer RK, Festing MF, and Riley J (1982) Haematology of conventionally-maintained Lac:P outbred Wistar rats during the 1st year of life. Lab Anim 16:198-200.
3. Bao WH, Dalferes ER, Srinivasan SR, Webber LS, and Berenson GS (1993) Normative distribution of complete blood count from early childhood through adolescence: the Bogalusa Heart Study. Prev Med 22:825-837.
4. Birkhill FR, Maloney MA, and Levenson SM (1951) Effect of transfusion polycythemia upon bone marrow activity and erythrocyte survival in man. Blood 6:1021-1033.
5. Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, De Cre MJ, and Bogaert MG (1989) Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 9:95-98.
6. Chapel SH, Veng-Pedersen P, Schmidt RL, and Widness JA (2000) A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. J Pharmacol Exp Ther 295:346-351.
7. Criswell KA, Sulkanen AP, Hochbaum AF, and Bleavins MR (2000) Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats. J Appl Toxicol 20:25-34.
8. D'Argenio DZ and Schumitzky A (1997) ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic System Analysis Software. Biomedical Simulations Resource, Los Angeles, CA.
9. 3H]DFP) method. Fundam Appl Toxicol 9:271-276.
10. Engstrom KG and Ohlsson L (1990) Morphology and filterability of red blood cells in neonatal and adult rats. Pediatr Res 27:220-226.
11. Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1-14.
12. Hartley C, Elliott S, Begley CG, McElroy P, Sutherland W, Khaja R, Heatherington AC, Graves T, Schultz H, Del Castillo J, et al. (2003) Kinetics of haematopoietic recovery after dose-intensive chemo/radiotherapy in mice: optimized erythroid support with darbepoetin alpha. Br J Haematol 122:623-636.
13. Jolling K, Ruixo JJ, Hemeryck A, Piotrovskij V, and Greway T (2004) Population pharmacokinetic analysis of pegylated human erythropoietin in rats. J Pharm Sci 93:3027-3038.
14. Kato M, Kamiyama H, Okazaki A, Kumaki K, Kato Y, and Sugiyama Y (1997) Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats. J Pharmacol Exp Ther 283:520-527.
15. Kato M, Okano K, Sakamoto Y, Miura K, Uchimura T, and Saito K (2001) Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats. Arzneim-Forsch 51:91-95.
16. Kinoshita H, Ohishi N, Kato M, Tokura S, and Okazaki A (1992) Pharmacokinetics and distribution of recombinant erythropoietin in rats. Arzneim-Forsch 42:174-178.
17. Kojima S, Haruta J, Enomoto A, Fujisawa H, Harada T, and Maita K (1999) Age-related hematological changes in normal F344 rats: during the neonatal period. Exp Anim 48:153-159.
18. Krzyzanski W, Jusko WJ, Wacholtz MC, Minton N, and Cheung WK (2005) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. Eur J Pharm Sci 26:295-306.
19. Krzyzanski W, Ramakrishnan R, and Jusko WJ (1999) Basic pharmacodynamic models for agents that alter production of natural cells. J Pharmacokinet Biopharm 27:467-489.
20. Laird C, Fox R, Mitchell B, Blau E, and Schultz H (1970) Effect of strain and age on some hematological parameters in the rabbit. Am J Physiol 218:1613-1617.
21. Laird AK (1964) Dynamics of tumor growth. Br J Cancer 13:490-502.
22. Mager DE, Wyska E, and Jusko WJ (2003) Diversity of mechanism-based pharmacodynamic models. Drug Metab Dispos 31:510-518.
23. Ramakrishnan R, Cheung WK, Farrell F, Joffee L, and Jusko WJ (2003) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys. J Pharmacol Exp Ther 306:324-331.
24. Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, and Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 44:991-1002.
25. Turton JA, Hawkey CM, Hart MG, Gwynne J, and Hicks RM (1989) Age-related changes in the haematology of female F344 rats. Lab Anim 23:295-301.
26. Veng-Pedersen P, Widness JA, Pereira LM, Peters C, Schmidt RL, and Lowe LS (1995) Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis: application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans. J Pharm Sci 84:760-767.
27. Veng-Pedersen P, Widness JA, Pereira LM, Schmidt RL, and Lowe LS (1999) A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans. Biopharm Drug Dispos 20:217-223.
28. Wintrobe MM (2003) Wintrobe's Clinical Hematology. Lippincott Williams & Wilkins, Philadelphia
29. Woo S, Krzyzanski W, and Jusko WJ (2004) Pharmacokinetic-pharmacodynamic modeling of recombinant human erythropoietin after single intravenous and subcutaneous dose administration in rats (Abstract). AAPS Pharm Sci 6:T3341.